Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
American Journal of Surgery|February 4, 2018
Association of shared decision-making on patient-reported health outcomes and healthcare utilizationTasha M Hughes, Katiuscha Merath, Qinyu Chen, et al.
Future Oncology (London, England)|June 6, 2014
The HELIOS trial protocol: a phase III study of ibrutinib in combination with bendamustine and rituximab in relapsed/refractory chronic lymphocytic leukemiaMichael Hallek, Neil E Kay, Anders Osterborg, et al.
Surgery|February 28, 2018
Influence of English proficiency on patient-provider communication and shared decision-makingAnghela Z Paredes, Jay J Idrees, Eliza W Beal, et al.
ACS Energy Letters|October 22, 2019
Surface Photovoltage-Induced Ultralow Work Function Material for Thermionic Energy ConvertersPeter Schindler, Daniel C Riley, Igor Bargatin, et al.
Circulation|April 30, 2003
Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trialChristie M Ballantyne, John Houri, Alberto Notarbartolo, et al.
Statistics in Biopharmaceutical Research|June 30, 2021
Assessing the Impact of COVID-19 on the Clinical Trial Objective and Analysis of Oncology Clinical Trials-Application of the Estimand FrameworkEvgeny Degtyarev, Kaspar Rufibach, Yue Shentu, et al.
Blood Advances|January 25, 2023
Clinical impact of ibrutinib plus R-CHOP in untreated DLBCL coexpressing BCL2 and MYC in the phase 3 PHOENIX trialPeter W M Johnson, Sriram Balasubramanian, Brendan Hodkinson, et al.
Journal of Surgical Oncology|October 31, 2018
Implementation and early outcomes for a surgeon-directed hepatic arterial infusion pump program for colorectal liver metastasesJeffery Chakedis, Eliza W Beal, Steven Sun, et al.
Cancer Medicine|November 18, 2021
Identification of a genetic signature enriching for response to ibrutinib in relapsed/refractory follicular lymphoma in the DAWN phase 2 trialSriram Balasubramanian, Brendan Hodkinson, Stephen J Schuster, et al.
Journal of Clinical Pharmacology|December 17, 2025
Population Pharmacokinetics of Bictegravir During Pregnancy and Postpartum: Role of Adherence in Maintaining Therapeutic ExposureSteven Sun, Mina Nikanjam, Mark Mirochnick, et al.
Pageof 6